Shannon M Monnat1, Danielle C Rhubart2, Sherrie Flynt Wallington3. 1. Department of Agricultural Economics, Sociology, and Education, Penn State University, 110B Armsby Bldg, University Park, PA, 16802, USA. smm67@psu.edu. 2. Department of Agricultural Economics, Sociology, and Education, Penn State University, 110B Armsby Bldg, University Park, PA, 16802, USA. dcr185@psu.edu. 3. Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Research Building, W326A, 3970 Reservoir Rd., Washington, DC, 20057, USA. slw49@georgetown.edu.
Abstract
OBJECTIVES: This study is among the first to examine metropolitan status differences in human papillomavirus (HPV) vaccine initiation and completion among United States adolescent girls and is unique in its focus on how maternal socioeconomic status and health care access moderate metropolitan status differences in HPV vaccination. METHODS: Using cross-sectional data from 3573 girls aged 12-17 in the U.S. from the 2008-2010 Behavioral Risk Factor Surveillance System, we estimate main and interaction effects from binary logistic regression models to identify subgroups of girls for which there are metropolitan versus non-metropolitan differences in HPV vaccination. RESULTS: Overall 34 % of girls initiated vaccination, and 19 % completed all three shots. On average, there were no metropolitan status differences in vaccination odds. However, there were important subgroup differences. Among low-income girls and girls whose mothers did not complete high school, those in non-metropolitan areas had significantly higher probability of vaccine initiation than those in metropolitan areas. Among high-income girls and girls whose mothers completed college, those in metropolitan areas had significantly higher odds of vaccine initiation than those in non-metropolitan areas. Moreover, among girls whose mothers experienced a medical cost barrier, non-metropolitan girls were less likely to initiate vaccination compared to metropolitan girls. CONCLUSIONS: Mothers remain essential targets for public health efforts to increase HPV vaccination and combat cervical cancer. Public health experts who study barriers to HPV vaccination and physicians who come into contact with mothers should be aware of group-specific barriers to vaccination and employ more tailored efforts to increase vaccination.
OBJECTIVES: This study is among the first to examine metropolitan status differences in human papillomavirus (HPV) vaccine initiation and completion among United States adolescent girls and is unique in its focus on how maternal socioeconomic status and health care access moderate metropolitan status differences in HPV vaccination. METHODS: Using cross-sectional data from 3573 girls aged 12-17 in the U.S. from the 2008-2010 Behavioral Risk Factor Surveillance System, we estimate main and interaction effects from binary logistic regression models to identify subgroups of girls for which there are metropolitan versus non-metropolitan differences in HPV vaccination. RESULTS: Overall 34 % of girls initiated vaccination, and 19 % completed all three shots. On average, there were no metropolitan status differences in vaccination odds. However, there were important subgroup differences. Among low-income girls and girls whose mothers did not complete high school, those in non-metropolitan areas had significantly higher probability of vaccine initiation than those in metropolitan areas. Among high-income girls and girls whose mothers completed college, those in metropolitan areas had significantly higher odds of vaccine initiation than those in non-metropolitan areas. Moreover, among girls whose mothers experienced a medical cost barrier, non-metropolitan girls were less likely to initiate vaccination compared to metropolitan girls. CONCLUSIONS: Mothers remain essential targets for public health efforts to increase HPV vaccination and combat cervical cancer. Public health experts who study barriers to HPV vaccination and physicians who come into contact with mothers should be aware of group-specific barriers to vaccination and employ more tailored efforts to increase vaccination.
Entities:
Keywords:
Adolescents; Cervical cancer; Human papillomavirus (HPV); Metropoltan versus non-metropolitan; Mothers; Sexually transmitted infections; USA; Vaccine
Authors: Jane Farmer; Lisa Iversen; Neil C Campbell; Clare Guest; Rosemary Chesson; George Deans; John MacDonald Journal: Health Place Date: 2006-06 Impact factor: 4.078
Authors: Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger Journal: MMWR Recomm Rep Date: 2007-03-23
Authors: Susan L Rosenthal; Richard Rupp; Gregory D Zimet; Heather M Meza; Melissa L Loza; Mary B Short; Paul A Succop Journal: J Adolesc Health Date: 2008-09 Impact factor: 5.012
Authors: Kelly Jo Sandri; Inge Verdenius; Mitchell J Bartley; Britney M Else; Christopher A Paynter; Beth E Rosemergey; George D Harris; Gerard J Malnar; Sean M Harper; R Stephen Griffith; Aaron J Bonham; Diane M Harper Journal: PLoS One Date: 2014-05-09 Impact factor: 3.240
Authors: Kathy L MacLaughlin; Robert M Jacobson; Jennifer L St Sauver; Debra J Jacobson; Chun Fan; Chung-Il Wi; Lila J Finney Rutten Journal: Vaccine Date: 2020-07-24 Impact factor: 3.641
Authors: Whitney E Zahnd; Natoshia Askelson; Robin C Vanderpool; Lindsay Stradtman; Jean Edward; Paige E Farris; Victoria Petermann; Jan M Eberth Journal: Prev Med Date: 2019-08-15 Impact factor: 4.018
Authors: Whitney E Zahnd; Aimee S James; Wiley D Jenkins; Sonya R Izadi; Amanda J Fogleman; David E Steward; Graham A Colditz; Laurent Brard Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-07-27 Impact factor: 4.254
Authors: Kevin A Henry; Allison L Swiecki-Sikora; Antoinette M Stroup; Echo L Warner; Deanna Kepka Journal: BMC Public Health Date: 2017-07-14 Impact factor: 3.295
Authors: Tanja Y Walker; Laurie D Elam-Evans; Charnetta L Williams; Benjamin Fredua; David Yankey; Lauri E Markowitz; Shannon Stokley Journal: Hum Vaccin Immunother Date: 2019-10-29 Impact factor: 3.452